US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist

44.500
+0.180+0.41%

Close Dec 13 16:00 ET

44.990
+0.490+1.10%

Post 20:02 ET

2.60BMarket Cap-17.26P/E (TTM)

Apogee Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Apogee Therapeutics Earnings Reports

Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results

Nov 12 09:49 ET

Apogee Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 09:31 ET

Apogee Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:05 ET

Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results

Aug 12 06:42 ET

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall